1. The Serum MicroRNA Signatures for Pancreatic Cancer Detection and Operability Evaluation
   Qiuliang Yan et al, 2020, Frontiers in Bioengineering and Biotechnology CrossRef
2. Therapeutically Targeting Epigenetic Regulation of Cancer Stem Cells
   Brendan Ffrench et al, 2015, Epigenetic Cancer Therapy CrossRef
3. The clinical significance of microRNA-409 in pancreatic carcinoma and associated tumor cellular functions
   Kui Long et al, 2021, Bioengineered CrossRef
4. Targeting microRNAs in Pancreatic Cancer: Microplayers in the Big Game
   Sheema Khan et al, 2013, Cancer Research CrossRef
5. Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patients
   Rui Zhang et al, 2014, Diagnostic Pathology CrossRef
6. Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis
   Ramadevi Subramani et al, 2014, PLoS ONE CrossRef
7. Targeted delivery systems for treatment of pancreatic cancer
   Melek Karaca et al, 2019, Nanoarchitectonics in Biomedicine CrossRef
8. Therapeutic Perspectives of Molecules from Urtica dioica Extracts for Cancer Treatment
   Sabrina Esposito et al, 2019, Molecules CrossRef
9. Physiological and Pathological Functions of Mammalian MicroRNAs
   X. Ma et al, 2018, Comprehensive Toxicology CrossRef
10. Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9
    Umashankar K. Ballehaninna et al, 2013, Tumor Biology CrossRef
11. Inhibition of microRNA-103a inhibits the activation of astrocytes in hippocampus tissues and improves the pathological injury of neurons of epilepsy rats by regulating BDNF
    Ping Zheng et al, 2019, Cancer Cell International CrossRef
12. miRNAs in pancreatic cancer: Therapeutic potential, delivery challenges and strategies
    Deepak Chitkara et al, 2015, Advanced Drug Delivery Reviews CrossRef
13. Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review)
    RAMADEVI SUBRAMANI et al, 2015, International Journal of Oncology CrossRef
14. miRNAs as colorectal cancer biomarkers: current progress and future challenges
    Niamh M Hogan et al, 2013, Colorectal Cancer CrossRef
15. Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties
    GUOPEI LUO et al, 2013, International Journal of Oncology CrossRef
16. A novel serum microRNA panel to discriminate benign from malignant ovarian disease
    Ream Langhe et al, 2015, Cancer Letters CrossRef
17. Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers
    Björn L. D. M. Brücher et al, 2016, Clinical and Translational Medicine CrossRef
18. Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions
    Yiyin Zhang et al, 2018, Journal of Hematology & Oncology CrossRef
19. Urtica dioica extract suppresses miR-21 and metastasis-related genes in breast cancer
    Behzad Mansoori et al, 2017, Biomedicine & Pharmacotherapy CrossRef
20. Pancreatic cancer stem cells: New insight into a stubborn disease
    Han-xiang Zhan et al, 2015, Cancer Letters CrossRef
21. Extensive cutaneous metastases of pancreatic adenocarcinoma: a case report and review of the literature
    Ioannis Kotsantis et al, 2017, Clinical Case Reports CrossRef
22. MicroRNA‐103a inhibits gastric cancer cell proliferation, migration and invasion by targeting c‐Myb
    Jinlong Liang et al, 2015, Cell Proliferation CrossRef
23. ROBO3 promotes growth and metastasis of pancreatic carcinoma
    Shilong Han et al, 2015, Cancer Letters CrossRef